{"id":"https://genegraph.clinicalgenome.org/r/f7733395-886b-45df-8a8e-83c89245fe3fv1.0","type":"EvidenceStrengthAssertion","dc:description":"Protein kinase C delta (*PRKCD*) was first reported in relation to autosomal recessive systemic lupus erythematosus (SLE) in 2013 (Belot et al, PMID: 23666743). Clinical reports have described affected individuals as having SLE, SLE-like, ALPS, ALPS-like, or CVID-like disease. While there is variability in severity of phenotype, per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no significant difference in molecular mechanism(s) or inheritance pattern. Therefore, the following disease entities have been lumped into one disease entity: Autoimmune lymphoproliferative syndrome, type III (OMIM:615559), and systemic lupus erythematosus (MONDO ID: 0007915). \n\nEleven variants (2 nonsense, 2 frameshift, 3 splicing, and 5 missense) have been reported in 10 probands in 8 publications (PMIDs: 23666743, 28003329, 34264265, 36650346, 26233237, 23319571, 23430113, 33047643) which are included in this curation. Of these ten probands, all had family members tested which confirmed segregation of the *PRKCD* variant with disease. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. \n\nThis gene-disease relationship is also supported by experimental evidence including animal models, expression studies, and *in vitro* functional assays (PMIDs: 23666743, 11976687, 23430113), all of which demonstrated that variants in *PRKCD* result in partial or complete loss of expression, reduced phosphorylation activity, and recapitulate human immune phenotypes in mice and patient cells. *PRKCD* mutant lymphoblastoid cell lines are resistant to apoptosis, but are rescued by coexpression of wild type protein. There is additional experimental evidence in Neehus et al. 2021 (PMID: 34264265), which was not included because the overall classification has reached the definitive level. \n\nIn summary, there is **definitive** evidence supporting the relationship between *PRKCD* and autosomal recessive systemic lupus erythematosus. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Monogenic Systemic and Incomplete Lupus Erythematosus GCEP on the meeting date October 11, 2024 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f7733395-886b-45df-8a8e-83c89245fe3f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10123","date":"2024-10-11T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10123","date":"2025-03-01T02:19:43.784Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1725bb62-77b1-4a5d-8e5d-83a307d5c6ff","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7f776fc-84ec-461f-a101-5d3c12873dab","type":"Finding","dc:description":"Recapitulates human phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11976687","rdfs:label":"Miyamoto 2002 Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2f179caf-3c40-4e23-9b51-3a109939a51b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e038bf0d-45c0-4ab0-9abd-901beaade4e8","type":"Finding","dc:description":"Recapitulated human phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","rdfs:label":"Belot 2013 HEK293T cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ac3f57e6-b408-4d90-a78a-a94e8b59d03f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2d297cd-5197-47fe-9ecd-c88c753dff0b","type":"Finding","dc:description":"Recapitulates human phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","rdfs:label":"Belot 2013 H157 cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/81c24704-75f3-4cff-85e0-e8e1b622cc0a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ec1f7ce-20ef-44f6-8b3f-3082b1f877e5","type":"Finding","dc:description":"PRKCD mutant LCLs are resistant to apoptosis and are rescued by coexpression of the wild-type protein","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","rdfs:label":"Belot 2013 Rescue in LCLs","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b17504f5-1eeb-4a00-92dd-648c75f428ea","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/649d341c-bed9-450a-b199-c1dad711f2e1","type":"Finding","dc:description":"Western blot","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430113","rdfs:label":"Kuehn et al. 2013 expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2407111a-4fd2-47fb-bb18-373acd33f85f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17099b04-c58f-461f-815e-8154a406287a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17099b04-c58f-461f-815e-8154a406287a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36650346","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b792673-ddc8-4909-b068-12242a168847","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.571C>T (p.Gln191Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2451828"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/58dc33ae-854d-4229-973e-c9b20adb37db","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58dc33ae-854d-4229-973e-c9b20adb37db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36650346","allele":{"id":"https://genegraph.clinicalgenome.org/r/4d9e98e0-8265-4a9d-9049-85f551c44428","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.788-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353220286"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2407111a-4fd2-47fb-bb18-373acd33f85f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36650346","rdfs:label":"Roderick 2023 II.2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":20,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/4d9e98e0-8265-4a9d-9049-85f551c44428"},{"id":"https://genegraph.clinicalgenome.org/r/0b792673-ddc8-4909-b068-12242a168847"}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"SLE Dx: severe infection onset 20 mo, early-onset SLE and SCID-like phenotypes in female proband\n•Moderate improvement following treatment with sirolimus and hydroxychloroquine. \n•Rituximab led to significant clinical and serological improvement in both sibs. Post-rituximab lab showed normalization of Ig M levels for both sibs. \nPre-treatment:\n• positive anticardiolipin Ab\n• anti-GAD antibodies \n•erythematous rash\n•ANA detectable but only at dilution of 1:20 (within normal reference range). \n• Severe opportunistic infections (viral+bac)\n• oral ulcers\n• haematopoietic stem cell transplantation at 6yo, acquired full donor chimerism in all cell lineages and off immunosuppressants since age 8\n","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/58dc33ae-854d-4229-973e-c9b20adb37db_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/17099b04-c58f-461f-815e-8154a406287a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8431c1a5-d183-4689-8283-28676f5e74a9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbb3c01c-3f6e-4ab4-a60d-a43a2362d1cd","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbb3c01c-3f6e-4ab4-a60d-a43a2362d1cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23319571","allele":{"id":"https://genegraph.clinicalgenome.org/r/590a0d98-9498-4525-8296-b2ea7f174036","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1352+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145457"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8431c1a5-d183-4689-8283-28676f5e74a9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23319571","rdfs:label":"Salzer 2013 Proband ","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/590a0d98-9498-4525-8296-b2ea7f174036"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"CVID-like phenotype, although the formal CVID criteria including decreased levels of at least 2 classes immunoglobulins were not fulfilled. anti-CD20 therapy alleviated autoantibody production.\nNephrotic syndrome onset age 15mo\nMembranous glomerulonephritis on biopsy\nRecurrent infections and severe lupus-like autoimmunity\nUrinary tract infections, gastroenteritis, upper and lower respiratory tract infections, and otitis media\nHepatosplenomegaly age 3\nTonsillectomy and adenoidectomy by age 4\nNonspecific reactive follicular hyperplasia on lymphnode biopsy\nDecreased CD19+ B cells \nA defective class switch indicated by low numbers of IgM- and IgG-memory B cells\nIncreased numbers of CD21low B cells\nPolychondritis\nLatent hypothyroidism \nAseptic endocarditis and pulmonary embolism age 8\nPositivity of anti-nuclear antibodies, anti-dsDNA, and anti-cardiolipin IgG antibodies\n\n\n\n","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cbb3c01c-3f6e-4ab4-a60d-a43a2362d1cd_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/842fc2a6-9c37-47f1-8c38-bacb3880d31a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce97eee2-fd4a-43b3-b89c-befc13a49bd1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 Kindred J","family":{"id":"https://genegraph.clinicalgenome.org/r/ce97eee2-fd4a-43b3-b89c-befc13a49bd1","type":"Family","rdfs:label":"Neehus 2021 Kindred J","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/82612e46-cd69-4911-8a1b-ba8bd279cf7b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 P16","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/bff4a7ac-9a6c-4565-817b-26e6489e2945","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.642del (p.Asn214LysfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573052226"}},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Female, BCG-itis Onset age 1\nNo SLE. Negative for antibodies:\n•ANA−\n•anti-dsDNA−\n•Bilateral anterior and posterior cervical adenopathies \n•Mild hepatosplenomegaly","previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/71d54a85-4e8e-4278-b0f6-77128f155610_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","allele":{"id":"https://genegraph.clinicalgenome.org/r/bff4a7ac-9a6c-4565-817b-26e6489e2945"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/82612e46-cd69-4911-8a1b-ba8bd279cf7b"}},{"id":"https://genegraph.clinicalgenome.org/r/5f9a1226-2c87-47d5-b33e-4266208a2375_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33047643","rdfs:label":"Sharifinejad 2022 Family","family":{"id":"https://genegraph.clinicalgenome.org/r/5f9a1226-2c87-47d5-b33e-4266208a2375","type":"Family","rdfs:label":"Sharifinejad 2022 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/9b771f65-418b-4364-99f6-2884bf0cec67","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33047643","rdfs:label":"Sharifinejad 2022 Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4a4f5f34-9b2a-4a22-9d44-0866ea55ebf7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1293_1294insA (p.Gly432ArgfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586972550"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":" •13-year-old boy who presented with ALPS-like symptoms; autoimmunity, lymphoproliferation, recurrent pneumonia, cardiomyopathy, and dermatological manifestations at 1 year of age. \n•Elevation of double-negative T cells, CD8+ T cells, serum IgG level\n•Reduction in NK cells\n•SLE ANA+\n•anti-dsDNA+\t\n•Infections w/ pneumonia, H. influenza. otitis media\n•Recurrent oral candidiasis, recurrent pneumonia, recurrent gastroenteritis","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/22503780-18a5-42a7-844e-66e810fd07ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33047643","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a4f5f34-9b2a-4a22-9d44-0866ea55ebf7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeFreeText":" •13-year-old boy who presented with ALPS-like symptoms; autoimmunity, lymphoproliferation, recurrent pneumonia, cardiomyopathy, and dermatological manifestations at 1 year of age. \n•Elevation of double-negative T cells, CD8+ T cells, serum IgG level\n•Reduction in NK cells\n•SLE ANA+\n•anti-dsDNA+\t\n•Infections w/ pneumonia, H. influenza. otitis media\n•Recurrent oral candidiasis, recurrent pneumonia, recurrent gastroenteritis","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/9b771f65-418b-4364-99f6-2884bf0cec67"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2a058049-a68f-40f4-930d-48f096ab267e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003329","rdfs:label":"Nanthapisal 2017 Family","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/2a058049-a68f-40f4-930d-48f096ab267e","type":"Family","rdfs:label":"Nanthapisal 2017 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/12bc2a0f-559c-4548-9f14-b0e248c06552","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003329","rdfs:label":"Nathanpisal 2017 V-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b3622c4-66e6-4b26-be19-f6d7bbc43869","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1294G>T (p.Gly432Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353222310"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Female presented at 12-months with scarring alopecia, scalp rash, photosensitive malar rash (figure 1A). \nHepatosplenomegaly and bruising of the skin (Figure 1B) and erythematous, non-pruritic, vasculitic rash affecting the hands and feet (Figure 1C and D). \nOral mucosa was normal. Other features were mild monoarthritis of the knee for more than 2 months & an episode of acute onset of fever, epistaxis, rectal bleeding and pancytopenia at the age of 3 years. -Elevated inflammatory markers (elevated ESR 125 mm/hour and CRP 30 mg/L), + anti-nuclear Ab 1:320, anti-dsDNA at 37 (normal < 10) & positive anti-extractable nuclear antigens\n","previousTesting":false,"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2d363a02-7608-43b3-a291-2d76d5236cee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003329","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b3622c4-66e6-4b26-be19-f6d7bbc43869"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/12bc2a0f-559c-4548-9f14-b0e248c06552"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/028a9dc0-6f05-4f99-b1a6-c5f8740e47f4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 Kindred H","estimatedLodScore":0.12,"family":{"id":"https://genegraph.clinicalgenome.org/r/028a9dc0-6f05-4f99-b1a6-c5f8740e47f4","type":"Family","rdfs:label":"Neehus 2021 Kindred H","member":{"id":"https://genegraph.clinicalgenome.org/r/c6b3db18-cd09-4ad9-8128-2a387d2bb644","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 P13","allele":{"id":"https://genegraph.clinicalgenome.org/r/3173ae2b-6ac0-4554-bbb4-b4d83bd465cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.571+2dup","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573052225"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Female, SLE dx onset 1 year; SLE ANA+; anti-dsDNA+; BCG-osis; Salmonella bacteremia; S. aureus inguinal lymphadenitis, recurrent gingivitis","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4c947e7a-712d-483f-8437-696777990dcf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","allele":{"id":"https://genegraph.clinicalgenome.org/r/3173ae2b-6ac0-4554-bbb4-b4d83bd465cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c6b3db18-cd09-4ad9-8128-2a387d2bb644"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5b6a3ce8-69b7-4018-b238-3737a1451bd2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23319571","rdfs:label":"Salzer 2013","estimatedLodScore":0.12,"family":{"id":"https://genegraph.clinicalgenome.org/r/5b6a3ce8-69b7-4018-b238-3737a1451bd2","type":"Family","rdfs:label":"Salzer 2013","member":{"id":"https://genegraph.clinicalgenome.org/r/8431c1a5-d183-4689-8283-28676f5e74a9"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8431c1a5-d183-4689-8283-28676f5e74a9"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e9ad725f-84a1-423c-91e5-9c1b73319441_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 Kindred I","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e9ad725f-84a1-423c-91e5-9c1b73319441","type":"Family","rdfs:label":"Neehus 2021 Kindred I","member":{"id":"https://genegraph.clinicalgenome.org/r/c1c8e727-bb42-44e3-ba75-46c8a7e1d436","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","rdfs:label":"Neehus 2021 P14","allele":{"id":"https://genegraph.clinicalgenome.org/r/30c4f7c1-566d-47bb-a3e9-3d35796c821f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1384C>T (p.Gln462Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353222800"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Male, SLE dx onset 7 months; Autoimmune hemolytic anemia; ANA+; hepatosplenomegaly; Fever; BCG-itis; recurrent gastroenteritis; Left axillary lymphadenopathy with purulent discharge; Lymph node biopsy showed granulomatous inflammation with no microbial cause identified upon culture.","previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6f8973a7-bee7-4dd9-9bf2-e127ca047dee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34264265","allele":{"id":"https://genegraph.clinicalgenome.org/r/30c4f7c1-566d-47bb-a3e9-3d35796c821f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Male, SLE dx onset 7 months; Autoimmune hemolytic anemia; ANA+; hepatosplenomegaly; Fever; BCG-itis; recurrent gastroenteritis; Left axillary lymphadenopathy with purulent discharge; Lymph node biopsy showed granulomatous inflammation with no microbial cause identified upon culture.","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c1c8e727-bb42-44e3-ba75-46c8a7e1d436"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ba50b4e0-1c1d-4507-9291-35caa3ad9d40_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","rdfs:label":"Belot 2013 SLE Family","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/ba50b4e0-1c1d-4507-9291-35caa3ad9d40","type":"Family","rdfs:label":"Belot 2013 SLE Family","member":{"id":"https://genegraph.clinicalgenome.org/r/da79c067-1b0d-4c5c-84da-a04f669b7107","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","rdfs:label":"Belot 2013 Proband V1","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8278e8d-e236-4f0c-8fa1-5b9b0383c2cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1528G>A (p.Gly510Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA171032"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"SLE Female w/ Skin involvement, alopecia, lupus nephritis, arthritis, neurologic involvement, dsDNA antibodies, ANAs, low C3 and C4, lympho-cytopenia, Hepatomegaly,Chronic cutaneous lupus, CNS vasculitis, chronic renal failure.\n","previousTesting":false,"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/277e5234-917f-420f-8711-714f627d825c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23666743","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8278e8d-e236-4f0c-8fa1-5b9b0383c2cc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All sibs fulfilled the ACR 1982 revised criteria for the classification of SLE\n","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/da79c067-1b0d-4c5c-84da-a04f669b7107"},"publishedLodScore":2.4,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/dd8d7b89-704a-414f-bad0-b46fedae2fbf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430113","rdfs:label":"Kuehn 2013 Family","estimatedLodScore":0.37,"family":{"id":"https://genegraph.clinicalgenome.org/r/dd8d7b89-704a-414f-bad0-b46fedae2fbf","type":"Family","rdfs:label":"Kuehn 2013 Family","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f0b61476-6617-4c6c-90e5-201bc53301dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430113","rdfs:label":"Kuehn 2013 Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f29e983f-5aae-443a-a242-a59d849f7691","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.1840C>T (p.Arg614Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA171034"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ALPS Male with early onset recurrent otitis with bilateral perforated tympanic membranes + sinusitis.\n• Intermittent fevers starting at age 3\n• Intermittent facial butterfly rash\n• Truncal confluent erythematous macules \n• Chronic lymphadenopathy, splenomegaly, autoantibodies, elevated immunoglobulins and NK dysfunction associated with chronic, low-grade EBV infection.\n• Lymph nodes showed intense follicular hyperplasia\n• B-cell hyperproliferation and defective apoptosis with consequent lymphocyte accumulation and autoantibody production \n• Reduced NK-cell cytolytic activity\n• Ab+ for ANAs, anti-RNP, anti-SSA, anti-Smith\n\n• Corticosteroids + rapamycin treatment reduced size of his lymph nodes and resolved hepatosplenomegaly\n","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe292298-1945-4ff9-b4ce-9ccad5c5bada_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430113","allele":{"id":"https://genegraph.clinicalgenome.org/r/f29e983f-5aae-443a-a242-a59d849f7691"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ALPS Male with early onset recurrent otitis with bilateral perforated tympanic membranes + sinusitis.\n• Intermittent fevers starting at age 3\n• Intermittent facial butterfly rash\n• Truncal confluent erythematous macules \n• Chronic lymphadenopathy, splenomegaly, autoantibodies, elevated immunoglobulins and NK dysfunction associated with chronic, low-grade EBV infection.\n• Lymph nodes showed intense follicular hyperplasia\n• B-cell hyperproliferation and defective apoptosis with consequent lymphocyte accumulation and autoantibody production \n• Reduced NK-cell cytolytic activity\n• Ab+ for ANAs, anti-RNP, anti-SSA, anti-Smith\n\n• Corticosteroids + rapamycin treatment reduced size of his lymph nodes and resolved hepatosplenomegaly\n","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f0b61476-6617-4c6c-90e5-201bc53301dd"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/64d834b5-8fdb-4579-be4c-ff1d9f09e084_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26233237","rdfs:label":"Kiykim 2015","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/64d834b5-8fdb-4579-be4c-ff1d9f09e084","type":"Family","rdfs:label":"Kiykim 2015","member":{"id":"https://genegraph.clinicalgenome.org/r/e43e68fc-3895-4dee-8963-680aea2a5e9c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26233237","rdfs:label":"Kiykim 2015","allele":{"id":"https://genegraph.clinicalgenome.org/r/46562e83-46dd-4b8a-b65a-647e42f1d285","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006254.4(PRKCD):c.742G>A (p.Gly248Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2451950"}},"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b54b418c-0b67-4fa3-a4af-b8b2c4319b02_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26233237","allele":{"id":"https://genegraph.clinicalgenome.org/r/46562e83-46dd-4b8a-b65a-647e42f1d285"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"“Lupus-like CVID”\n Dx: 3.5 yo male with SLE. \n•Neonatal resp distress\n•Erythematosus skin\nrash \n•Recurrent fever\n•Thrombocytopenia\n• Hepatosplenomegaly\n•Slight decrease of T cell proliferation\n• Moderate decrease in NK-cytolytic activity\n•Negative for autoantibodies including ANA, anti-dsDNA, anti-thyroglobulin and anti-thyroid peroxidase at 18 months\n• Positive for ANA at 2.5 years\n•Low serum C3 and C4\n•No hematuria or proteinuria.\n•Basal membrane degeneration and apoptosis compatible with vasculitis on skin biopsy\n•Cutaneous lupus erythematosus was confirmed by skin\nbiopsy\nCMV infection and an early onset SLE-like disorder was successfully treated with hydroxychloroquine (post-treatment, proband showed significant reduction in lymph node, spleen and liver size, increase in switched\nmemory B cells, resolution of skin lesions) \n","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e43e68fc-3895-4dee-8963-680aea2a5e9c"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/386a359a-724f-4dca-ae2d-c68770c13ee4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36650346","rdfs:label":"Roderick 2023 Family","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/386a359a-724f-4dca-ae2d-c68770c13ee4","type":"Family","rdfs:label":"Roderick 2023 Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2407111a-4fd2-47fb-bb18-373acd33f85f"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2407111a-4fd2-47fb-bb18-373acd33f85f"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/f0b61476-6617-4c6c-90e5-201bc53301dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe292298-1945-4ff9-b4ce-9ccad5c5bada","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe292298-1945-4ff9-b4ce-9ccad5c5bada_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot analysis revealed low levels of PKCδ protein expression in the patient’s PBMCs","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fe292298-1945-4ff9-b4ce-9ccad5c5bada_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f0b61476-6617-4c6c-90e5-201bc53301dd"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9b771f65-418b-4364-99f6-2884bf0cec67_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22503780-18a5-42a7-844e-66e810fd07ac","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22503780-18a5-42a7-844e-66e810fd07ac_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9b771f65-418b-4364-99f6-2884bf0cec67"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/82612e46-cd69-4911-8a1b-ba8bd279cf7b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71d54a85-4e8e-4278-b0f6-77128f155610","type":"EvidenceLine","dc:description":"This individual and her sibling did not have SLE. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71d54a85-4e8e-4278-b0f6-77128f155610_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/82612e46-cd69-4911-8a1b-ba8bd279cf7b"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/da79c067-1b0d-4c5c-84da-a04f669b7107_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/277e5234-917f-420f-8711-714f627d825c","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/277e5234-917f-420f-8711-714f627d825c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fig 2A - Western blot of HEK293 cells showed PRKCD could not be phosphorylated at the activation loop (T507), resulting in an decrease in phosphorylation at the turn motif (S645) and the hydrophobic motif (S662) \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/277e5234-917f-420f-8711-714f627d825c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/da79c067-1b0d-4c5c-84da-a04f669b7107"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e43e68fc-3895-4dee-8963-680aea2a5e9c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b54b418c-0b67-4fa3-a4af-b8b2c4319b02","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b54b418c-0b67-4fa3-a4af-b8b2c4319b02_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In Immortalized B cells from proband, slight decrease in PRKCD was observed, and the levels of phosphorylated MARCKS (p-MARCKS) substantially decreased, when compared to normal donor controls (Fig 2B)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b54b418c-0b67-4fa3-a4af-b8b2c4319b02_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e43e68fc-3895-4dee-8963-680aea2a5e9c"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c6b3db18-cd09-4ad9-8128-2a387d2bb644_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c947e7a-712d-483f-8437-696777990dcf","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c947e7a-712d-483f-8437-696777990dcf_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c6b3db18-cd09-4ad9-8128-2a387d2bb644"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/12bc2a0f-559c-4548-9f14-b0e248c06552_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d363a02-7608-43b3-a291-2d76d5236cee","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d363a02-7608-43b3-a291-2d76d5236cee_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/12bc2a0f-559c-4548-9f14-b0e248c06552"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c1c8e727-bb42-44e3-ba75-46c8a7e1d436_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f8973a7-bee7-4dd9-9bf2-e127ca047dee","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f8973a7-bee7-4dd9-9bf2-e127ca047dee_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c1c8e727-bb42-44e3-ba75-46c8a7e1d436"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10041,"specifiedBy":"GeneValidityCriteria11","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/hFnOFiJWc7w","type":"GeneValidityProposition","disease":"obo:MONDO_0007915","gene":"hgnc:9399","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_842fc2a6-9c37-47f1-8c38-bacb3880d31a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}